Trademark: 90481704
Status Date
Tuesday, January 9, 2024
Filing Date
Friday, January 22, 2021
Published for Opposition
Tuesday, November 16, 2021
40 Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for health care, for the treatment of humans suffering from diseases treated by cell therapy or regenerative medicine products, more specifically medicines for human use as well as medicines for experimental medical and therapeutic uses, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies
5 Pharmaceutical preparations for T Cell therapy; pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of cancer, autoimmune diseases, and immunological disorders; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; chemical and biochemical preparations for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases and immunological disorders; biochemical, namely, monoclonal antibodies for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases and immunological disorders
44 Providing information regarding the treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders by means of a website
The wording Abata has no meaning in a foreign language.
Feb 16, 2024
Teas Change Of Correspondence Received
Feb 16, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 16, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 11, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2024
Sou Extension 4 Granted
Jan 9, 2024
Sou Extension 4 Filed
Jan 9, 2024
Sou Teas Extension Received
Jun 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2023
Sou Extension 3 Granted
Jun 28, 2023
Sou Extension 3 Filed
Jun 28, 2023
Sou Teas Extension Received
Jan 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2023
Sou Extension 2 Granted
Jan 3, 2023
Sou Extension 2 Filed
Jan 3, 2023
Sou Teas Extension Received
Jul 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 7, 2022
Sou Extension 1 Granted
Jul 7, 2022
Sou Extension 1 Filed
Jul 7, 2022
Sou Teas Extension Received
Jan 11, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 16, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 16, 2021
Published For Opposition
Oct 27, 2021
Notification Of Notice Of Publication E-Mailed
Oct 8, 2021
Approved For Pub - Principal Register
Oct 7, 2021
Teas/Email Correspondence Entered
Oct 7, 2021
Correspondence Received In Law Office
Oct 7, 2021
Teas Response To Office Action Received
Sep 29, 2021
Automatic Update Of Assignment Of Ownership
Sep 28, 2021
Teas Change Of Correspondence Received
Sep 28, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 28, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 12, 2021
Notification Of Non-Final Action E-Mailed
Aug 12, 2021
Non-Final Action E-Mailed
Aug 12, 2021
Non-Final Action Written
Aug 9, 2021
Assigned To Examiner
May 27, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
May 27, 2021
Teas Change Of Correspondence Received
May 27, 2021
Teas Change Of Owner Address Received
Apr 23, 2021
New Application Office Supplied Data Entered
Jan 26, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
